Lv63
2090 积分 2022-07-12 加入
Efficacy and Safety of Ofatumumab Treatment for Anti‐NMDA Receptor Autoimmune Encephalitis (OFF‐AE): A Prospective, Multicenter Cohort Study
1小时前
待确认
Correction: Iptacopan: First Approval
16天前
已完结
Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis
22天前
已完结
Efficacy of Alcaftadine 0.25% (AGN-229666) for Once-daily Prevention of Cedar-Pollen Allergic Conjunctivitis: A Phase 3 Randomized Study
22天前
已完结
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
1个月前
已关闭
Treatment of Allergic Conjunctivitis: Results of a 1-Month, Single-Masked Randomized Study
2个月前
已完结
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
2个月前
已完结
JACQLQ subjective symptom questionnaire score and clinical test results for patients with allergic conjunctival disease
2个月前
已完结
Allergen immunotherapy: A practice parameter third update
2个月前
已完结
Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge
2个月前
已完结
皖公网安备34019202002308
